Clinical Trial Update: STELLAREX: ILLUMENATE Global and In-Stent Restenosis (ISR) [NA]

View source ↗

Summary

Clinical trial update for STELLAREX: ILLUMENATE in-Stent Restenosis in peripheral arterial disease; study completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Arterial Disease

Drugs mentioned

• ILLUMENATE
• STELLAREX

Snippet

Sponsor: Spectranetics Corporation | Conditions: Peripheral Arterial Disease | NA | Status: COMPLETED | Results posted: 2022-03-15